Jeffrey B Geske

20PUBLICATIONS
143CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Gene and molecular therapyRadiology and organ imagingArtificial life and complex adaptive systemsOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 04, 2026
Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy.

Ramzi Ibrahim, Winston Wang, Hoang Nhat Pham

|Sep 06, 2025
Atrioventricular node ablation for refractory atrial fibrillation in patients with hypertrophic cardiomyopathy: a case-control study.

Julia G Debertin, William H Swain, Brett C Austin

|May 16, 2025
Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis.

Kamal Awad, Milagros Pereyra Pietri, Juan M Farina

|Mar 31, 2025
Long-Term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights From VALOR-HCM Trial.

Milind Y Desai, Anjali Owens, Sara Saberi

|Mar 31, 2025
Mucopolysaccharidosis Type IIIA Presenting as Hypertrophic Cardiomyopathy.

Filippo Pinto E Vairo, Jeffrey B Geske, Ravinder J Singh

Pageof 4